Adaptive Biotechnologies (NASDAQ:ADPT) reported its Q3 earnings results on Thursday, November 9, 2023 at 04:05 PM.
Here’s what investors need to know about the announcement.
Earnings
Adaptive Biotechnologies missed estimated earnings by 2.94%, reporting an EPS of $-0.35 versus an estimate of $-0.34.
Revenue was down $9.91 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.0 which was followed by a 12.44% drop in the share price the next day.
Here’s a look at Adaptive Biotechnologies’s past performance:
| Quarter | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.33 | -0.38 | -0.35 | -0.37 |
| EPS Actual | -0.33 | -0.40 | -0.28 | -0.32 |
| Revenue Estimate | 45.48M | 36.81M | 55.27M | 48.67M |
| Revenue Actual | 48.93M | 37.65M | 55.20M | 47.83M |
To track all earnings releases for Adaptive Biotechnologies visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
